Cetkovic-Cvrlje M, Rogan S, Barbaro E. Garcinia kola treatment exhibits immunomodulatory properties while not affecting type 1 diabetes development in an experimental mouse model.
Int J Immunopathol Pharmacol 2022. [PMCID:
PMC8777369 DOI:
10.1177/20587384211069831]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Objective
T cells orchestrate an inflammatory response that destroys pancreatic insulin-producing
β cells during the development of autoimmune type 1 diabetes (T1D). Garcinia
kola Heckel (GK) is a plant widely exploited in West African traditional
medicine. Some of the therapeutic effects of GK nut’s extract (GKE) have been suggested
to be due to its anti-inflammatory potential. Since GKE has never been investigated in a
T1D experimental model, nor in the T cells’ context, we aimed to determine whether GKE
exhibits antidiabetic properties and affects T cells by its anticipated
anti-inflammatory action.
Methods
The effect of aqueous GKE (aGKE) ingestion, 100 mg/kg daily by drinking water over the
period of 6 weeks, has been tested in a low-dose streptozotocin-induced (LDSTZ) mouse
model of autoimmune T1D. T cells were studied in vitro and in
vivo in mice treated by aGKE.
Results
The results showed that aGKE treatment, which started a week before induction of
disease, neither delayed the development of T1D, nor reduced glycemia severity.
Interestingly, aGKE treatment did affect T cells and their function, significantly
decreasing the frequency of helper (TH) and cytotoxic (TC) T
cells, while elevating the levels of pro-inflammatory cytokines, TNF-α, IL-6, and IFN-γ,
and suppressing IL-2.
Conclusion
In conclusion, our results did not confirm the antidiabetic property of GKE, while
suggesting its therapeutic exploration in TH2-dependent pathologies that
benefit from an aggravated TH1 response, such as allergies.
Collapse